Data analysis

OSE Immunotherapeutics Reports Full Year 2023 Financial Results and Provides Business Strategy Update

Retrieved on: 
Wednesday, March 27, 2024
Oncology, Health, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, HCC, AbbVie, GPCR, Ulcerative colitis, Head, Alpha globulin, Survival, Data science, Data analysis, Drug discovery, Partnership, Hook effect, HNSCC, Boehringer Ingelheim, Inflammation, Patient, Research, RNA, Veloxis Pharmaceuticals, Cancer, Lung cancer, Bank statement, AACR, Investment, First, Therapy, ESMO, Collaboration, Hepatocellular carcinoma, RNA therapeutics, FDA, Artificial intelligence, Audit committee, Food, Pharmaceutical industry

OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today reported its consolidated annual financial results for 2023 and provided an update on key proprietary clinical and preclinical achievements, on ongoing collaboration and licensing agreements, as well as on the 2024 Company’s outlook.

Key Points: 
  • OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today reported its consolidated annual financial results for 2023 and provided an update on key proprietary clinical and preclinical achievements, on ongoing collaboration and licensing agreements, as well as on the 2024 Company’s outlook.
  • Anne-Laure Autret-Cornet, Chief Financial Officer of OSE Immunotherapeutics, adds: “Our business-model is mostly based on recurrent and strategic partnerships with pharmaceutical companies.
  • A meeting of the Board of Directors of OSE Immunotherapeutics was held on March 27, 2024.
  • Following the Audit Committee opinion, the Board approved the annual and consolidated financial statements prepared under IFRS on 31 December 2023.

Swarm Intelligence Market Size, Share & Trends Analysis Report 2024: Optimization Solutions Dominate - Global Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 27, 2024
Technology, Artificial Intelligence, Environmental monitoring, Algorithm, Growth, Transport, Data analysis, Ant colony optimization algorithms, Agriculture, Application, Biodiversity, Capability, Robotics, Paramount, Particle swarm optimization, USD, Retail

The "Swarm Intelligence Market Size, Share & Trends Analysis Report By Model (Ant Colony Optimization, Particle Swarm Optimization, Others), By Capability, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Swarm Intelligence Market Size, Share & Trends Analysis Report By Model (Ant Colony Optimization, Particle Swarm Optimization, Others), By Capability, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global swarm intelligence market size is anticipated to reach USD 306.1 million by 2030 and is anticipated to grow at a CAGR of 38.4% from 2024 to 2030.
  • The increasing complexity of problem-solving requirements in numerous industries, such as automotive & transportation, healthcare & life science, agriculture, and others, fuels the demand for swarm intelligence.
  • By leveraging collective intelligence, Swarm intelligence addresses complex problems ranging from financial modeling and optimization to data analysis.

Phocas Software Rolls Out AI to 2050 Companies That Use Its Business Intelligence

Retrieved on: 
Tuesday, March 26, 2024
Other Manufacturing, Technology, Professional Services, Software, Manufacturing, Data Analytics, Data Management, Supply Chain Management, Retail, Artificial Intelligence, Financial statement, Database, Software as a service, Learning, Data analysis, HVACR, Janes, Interview, Business process management, AI, Learning curve, Phocas Software, Medical device

Phocas AI uses a natural language processing model and can turbo charge all departments' access to information leading to more informed decisions across the business.

Key Points: 
  • Phocas AI uses a natural language processing model and can turbo charge all departments' access to information leading to more informed decisions across the business.
  • So far, the new AI feature in Analytics is proving most valuable for newcomers to business intelligence.
  • Tim Janes, Process Manager at Johnstone Supply says since the introduction of Phocas AI in Analytics, more people in the business want to try it out.
  • “Phocas AI is made to work across all departments, and everyone can tap into fast insights at every level of a business.

Hayden AI and Snapper Services Partner to Enhance Public Transit Data Analysis

Retrieved on: 
Tuesday, March 26, 2024
Software, Technology, Artificial Intelligence, Data Management, Data analysis, Partnership, Transport, Punctuality, Safety, Disability

Hayden AI, a global leader in vision AI and spatial analytics, and Snapper Services, creators of the Mosaiq Transit Intelligence Suite, today announced a new partnership to enhance data analysis for public transport providers.

Key Points: 
  • Hayden AI, a global leader in vision AI and spatial analytics, and Snapper Services, creators of the Mosaiq Transit Intelligence Suite, today announced a new partnership to enhance data analysis for public transport providers.
  • Hayden AI’s vision AI platform is installed on hundreds of transit buses for automated bus lane and bus stop enforcement.
  • We’re excited to take that understanding a level deeper with Mosaiq’s analysis tools,” said Chris Carson, founder and CEO of Hayden AI.
  • Attendees and media representatives can learn more about Snapper and Hayden AI’s partnership at Hayden AI’s booth (#5.203).

Corvias Military Housing Advances Enhanced Quality Assurance and Quality Control Program

Retrieved on: 
Tuesday, March 26, 2024
Other Defense, Defense, Quality control, QA/QC, MHA, Culture, Data analysis, DOD, Housing, Curriculum, Multimedia, Work, Army, Nursing

Corvias tailored its Quality Assurance/Quality Control (QA/QC) program to provide a comprehensive framework for enhancing living conditions and improving resident satisfaction.

Key Points: 
  • Corvias tailored its Quality Assurance/Quality Control (QA/QC) program to provide a comprehensive framework for enhancing living conditions and improving resident satisfaction.
  • (Photo: Business Wire)
    Led by Melissa Bryson, regional vice president of compliance and quality control, the program focuses on developing, implementing, and monitoring standard operating procedures across Corvias' Department of Defense privatized military housing portfolio.
  • To align with the GAO report’s recommendations and Army requirements, Bryson explains, “Corvias developed a robust and thorough QA/QC program.
  • Working with private-sector Military Housing Privatization Initiative (MHPI) companies – including Corvias - to accelerate project investment to renovate or construct new housing units and upgrade existing privatized housing.

Beckley Psytech announces positive initial data from Phase IIa study of novel 5-MeO-DMT formulation BPL-003 for Treatment Resistant Depression

Retrieved on: 
Wednesday, March 27, 2024
Science, Biotechnology, Research, Pharmaceutical, Health, Mental Health, Clinical Trials, Other Health, Depression, Atypical depression, Data analysis, MDD, Patient, Beckley Foundation, DSM-IV codes, TRD, Treatment, Drug development, Safety, Phase, FDA, 5-MeO-DMT, Pharmaceutical industry

95% of events were mild or moderate, and no serious adverse events were reported which is broadly consistent with Phase I findings .

Key Points: 
  • 95% of events were mild or moderate, and no serious adverse events were reported which is broadly consistent with Phase I findings .
  • Acute effects were resolved and patients were deemed dischargeable within an average time of less than 2 hours.
  • Our single dose treatment model enables a short treatment duration which positions BPL-003 as a potentially exciting and scalable treatment opportunity.
  • The company’s lead compound, BPL-003, is a novel, synthetic 5-MeO-DMT benzoate salt candidate currently under investigation for the treatment of Treatment Resistant Depression (TRD) and Alcohol Use Disorder (AUD).

NetRoadshow Evolves Capital Markets with Generative AI Capabilities

Retrieved on: 
Monday, March 25, 2024
Banking, Software, Professional Services, Fintech, Data Management, Apps, Applications, Technology, Digital Cash Management, Digital Assets, Artificial Intelligence, Security, Other Professional Services, Finance, Other Technology, Research, Data analysis, Medical device

NetRoadshow today unveiled a suite of time-saving AI research capabilities integrated into its capital markets deal marketing platform.

Key Points: 
  • NetRoadshow today unveiled a suite of time-saving AI research capabilities integrated into its capital markets deal marketing platform.
  • “We are thrilled to pioneer the introduction of generative AI capabilities into our market, and the productivity improvements it will provide to our clients,” says Brad Hammond, CEO at NetRoadshow.
  • Looking ahead, NetRoadshow is committed to further advancing AI capabilities on its platform to enhance existing products and offer customers expanded functionality and utility.
  • AI research capabilities in the NetRoadshow platform are available starting today, March 25, 2024.

Technology Advancement Center Expands Leadership Team with Three Key Hires

Retrieved on: 
Monday, March 25, 2024
Software, Mobile, Wireless, Networks, Other Defense, Internet, Data Management, Technology, Defense, Security, Homeland Security, Other Technology, Public Policy, Government, CIO, Culture, SIGINT, Data analysis, Intelligence, Risk, Security agency, Technical, USCYBERCOM, Small business, Teal, Senior advisor, NSA, STEM, Air force, Creativity, Safety, Workforce, Navy, Management

The Technology Advancement Center (TAC), a cybersecurity nonprofit driving small business and academic engagement, STEM and workforce development opportunities, and proof of concept innovation, proudly announces three new leadership hires: Monty Mills as Chief Information Officer, Greg Wessel as Chief Technology Officer, and Tim Teal as Senior Advisor.

Key Points: 
  • The Technology Advancement Center (TAC), a cybersecurity nonprofit driving small business and academic engagement, STEM and workforce development opportunities, and proof of concept innovation, proudly announces three new leadership hires: Monty Mills as Chief Information Officer, Greg Wessel as Chief Technology Officer, and Tim Teal as Senior Advisor.
  • “Hand selected for their expertise and backgrounds in both government and technology, these leaders will play key roles in expanding TAC’s ability to support the innovation needed to advance our nation’s cyber capabilities.
  • Wessel said, “I’m eager to work with TAC’s leadership to implement new and cutting-edge infrastructure for the organization.
  • For more information about TAC, including details about upcoming events and opportunities to network with the industry, please visit https://thetac.tech/.

MiLaboratories Introduces Platforma Bio: A Revolutionary UI-First Computational Biology Platform powered by AI

Retrieved on: 
Monday, March 25, 2024
Technology, Research, Stem Cells, Software, Biotechnology, Health, Other Science, Science, Artificial Intelligence, Computational biology, Multimedia, NGS, Organization, Interest, UI, AI, Data analysis, Online shopping

MiLaboratories, a leader in developing best-in-class software for immunological data analysis, proudly announces the official launch of Platforma.bio .

Key Points: 
  • MiLaboratories, a leader in developing best-in-class software for immunological data analysis, proudly announces the official launch of Platforma.bio .
  • This groundbreaking computational biology platform, powered by AI large language models, is designed to significantly streamline, and simplify biological analysis, making it more accessible to researchers across various disciplines.
  • Platforma.bio stands out in the computational biology field with its unique, patent-pending engine that effectively identifies and eliminates redundant computations.
  • To introduce Platforma.bio to the research community, MiLaboratories will host a detailed webinar showcasing its features and practical applications.

Confluence Integrates MSCI ESG Research Data Into Its Style Analytics Solution

Retrieved on: 
Monday, March 25, 2024
Technology, Finance, Consulting, Banking, Professional Services, Data Analytics, Data Management, Environmental, Social and Governance (ESG), Asset Management, Other Professional Services, Research, Style, ESG, MSCI, Confluence (company), United Nations, Confluence, Data analysis

Confluence Technologies, Inc. (“Confluence”), a global technology solutions provider for regulatory and investor communications for the investment management industry, announced today it is integrating comprehensive MSCI ESG Research data into its leading factor investing analytics solution, Style Analytics.

Key Points: 
  • Confluence Technologies, Inc. (“Confluence”), a global technology solutions provider for regulatory and investor communications for the investment management industry, announced today it is integrating comprehensive MSCI ESG Research data into its leading factor investing analytics solution, Style Analytics.
  • “Style Analytics’ integration of MSCI’s comprehensive ESG data marks a significant step to help our clients make informed investment decisions and achieve sustainable growth.”
    The overlay of MSCI ESG Research data into Style Analytics allows for drill-down capabilities, fund-of-funds capabilities for United Nations SDGs, and analytics, alongside factor analysis on a simple, intuitive user interface.
  • Style Analytics’ MSCI drill-down module comes at a time of growing interest in sustainability and ESG investing and the resultant need for ESG data and technology.
  • To learn more about Style Analytics’ module featuring MSCI ESG Research data, including the onboarding process, initial consultation, platform demonstration, data integration, and training, please contact Confluence by visiting our website at confluence.com/StyleMSCI .